Julie Litz

The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.

Geoffrey W. Krystal, Sittisak Honsawek, Julie Litz et al. · PubMed · 2000 · 267 citations

Oncology, Chemoprevention Strategy, Tumor Microenvironment +15

The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy

G. Sakuntala Warshamana-Greene, Julie Litz, Elisabeth Buchdunger et al. · Clinical Cancer Research · 2005 · 189 citations

Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.

Geoffrey W. Krystal, Geoffrey Sulanke, Julie Litz · PubMed · 2002 · 170 citations

Apoptosis, Immunology, Cell Death +21

Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer

Anna Rodina, Maria Vilenchik, Kamalika Moulick et al. · Nature Chemical Biology · 2007 · 155 citations

Major Inhibitor, Medicine, Apoptosis +9

A 42-kD tyrosine kinase substrate linked to chromaffin cell secretion exhibits an associated MAP kinase activity and is highly related to a 42-kD mitogen-stimulated protein in fibroblasts.

Constance M. Ely, K M Oddie, Julie Litz et al. · The Journal of Cell Biology · 1990 · 142 citations · Full text

Protein Secretion, Bovine Chromaffin Cells, Cellular Physiology +19